Genome editing or small molecule inhibition of KMT5A in CAR-T cells enhances antitumor immunity
Background
Adoptive T-cell therapy has emerged as a promising therapeutic strategy for cancer treatment. However, clinical challenges persist, including the limited ability of CD8+T cells to infiltrate solid tumors and efficiently eliminate tumor cell…